• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸性粒细胞与儿童哮喘。

Eosinophils and childhood asthma.

作者信息

Choi Bong Seok

机构信息

Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Korea.

出版信息

Clin Exp Pediatr. 2021 Feb;64(2):60-67. doi: 10.3345/cep.2020.00717. Epub 2021 Jan 6.

DOI:10.3345/cep.2020.00717
PMID:33445830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7873389/
Abstract

Eosinophils are a type of granulocyte with eosinophilic granules in the cytoplasm that play an important role in allergic and parasitic diseases. Eosinophils are important in the pathogenesis of asthma, and many studies have examined the relationship between them. In allergic eosinophilic asthma, eosinophils act not only as important effector cells but also as antigen-presenting cells in allergic inflammatory reactions. In nonallergic eosinophilic asthma, type 2 innate lymphoid cells in the airways play an important role in eosinophil activation. Direct methods, including bronchial biopsy, bronchoalveolar lavage, and the induced sputum test, are used to evaluate eosinophilic inflammatory reactions in patients with asthma, however, because of difficulty with their implementation, they are sometimes replaced by measurements of blood eosinophils, fraction of exhaled nitric oxide, and serum periostin level. However, these tests are less accurate than direct methods. For the treatment of patients with severe eosinophilic asthma, anti-interleukin-5 preparations such as mepolizumab, reslizumab, and benralizumab have recently been introduced and broadened the scope of asthma treatment. Although eosinophils are already known to play an important role in asthma, we expect that further studies will reveal more details of their action.

摘要

嗜酸性粒细胞是一种粒细胞,其细胞质中含有嗜酸性颗粒,在过敏性疾病和寄生虫病中起重要作用。嗜酸性粒细胞在哮喘的发病机制中很重要,许多研究都探讨了它们之间的关系。在过敏性嗜酸性粒细胞性哮喘中,嗜酸性粒细胞不仅作为重要的效应细胞,而且在过敏性炎症反应中作为抗原呈递细胞发挥作用。在非过敏性嗜酸性粒细胞性哮喘中,气道中的2型固有淋巴细胞在嗜酸性粒细胞活化中起重要作用。直接方法,包括支气管活检、支气管肺泡灌洗和诱导痰试验,用于评估哮喘患者的嗜酸性粒细胞炎症反应,然而,由于实施困难,它们有时被血液嗜酸性粒细胞测量、呼出一氧化氮分数和血清骨膜蛋白水平测量所取代。然而,这些检测方法不如直接方法准确。对于重度嗜酸性粒细胞性哮喘患者的治疗,最近引入了抗白细胞介素-5制剂,如美泊利单抗、瑞利珠单抗和贝那利珠单抗,拓宽了哮喘治疗的范围。尽管嗜酸性粒细胞在哮喘中的重要作用已为人所知,但我们预计进一步的研究将揭示其作用的更多细节。

相似文献

1
Eosinophils and childhood asthma.嗜酸性粒细胞与儿童哮喘。
Clin Exp Pediatr. 2021 Feb;64(2):60-67. doi: 10.3345/cep.2020.00717. Epub 2021 Jan 6.
2
Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma.美泊利单抗可减少哮喘患者气道中的嗜酸性粒细胞数量,但不改变其功能表型。
Am J Respir Crit Care Med. 2017 Dec 1;196(11):1385-1395. doi: 10.1164/rccm.201611-2234OC.
3
Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab.体重调整的静脉注射瑞利珠单抗治疗对固定剂量皮下美泊利珠单抗应答不足的重症哮喘。
Am J Respir Crit Care Med. 2018 Jan 1;197(1):38-46. doi: 10.1164/rccm.201707-1323OC.
4
Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.血清 IgE 浓度预测重度嗜酸性粒细胞性哮喘患者恶化风险和 benralizumab 疗效的能力。
Adv Ther. 2020 Feb;37(2):718-729. doi: 10.1007/s12325-019-01191-2. Epub 2019 Dec 14.
5
Expression of eosinophil β chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma.严重非变应性嗜酸性粒细胞性哮喘中外周血嗜酸性粒细胞β链信号细胞因子受体、外膜整合素和 2 型炎症生物标志物的表达。
BMC Pulm Med. 2019 Aug 22;19(1):158. doi: 10.1186/s12890-019-0904-9.
6
Biomarkers of eosinophilic inflammation in asthma.哮喘中嗜酸性粒细胞炎症的生物标志物。
Expert Rev Respir Med. 2014 Apr;8(2):143-50. doi: 10.1586/17476348.2014.880052. Epub 2014 Jan 27.
7
Anti-IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL). A Placebo-controlled, Double-Blind Study.抗白细胞介素-5 治疗轻度哮喘对鼻病毒诱导的巨噬细胞、B 细胞和中性粒细胞反应的影响(材料)。一项安慰剂对照、双盲研究。
Am J Respir Crit Care Med. 2019 Feb 15;199(4):508-517. doi: 10.1164/rccm.201803-0461OC.
8
Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma.抗白细胞介素-5治疗在难治性嗜酸性粒细胞性哮喘管理中的疗效和安全性证据。
Ther Adv Respir Dis. 2015 Aug;9(4):135-45. doi: 10.1177/1753465815581279. Epub 2015 Apr 21.
9
The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions.嗜酸性粒细胞的新作用:对嗜酸性粒细胞相关炎症性疾病靶向治疗的启示。
Curr Res Immunol. 2022 Mar 21;3:42-53. doi: 10.1016/j.crimmu.2022.03.002. eCollection 2022.
10
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy.倍利珠单抗治疗重度哮喘:设计、研发及在治疗中的潜在地位
Drug Des Devel Ther. 2018 Mar 21;12:619-628. doi: 10.2147/DDDT.S155307. eCollection 2018.

引用本文的文献

1
Seasonal variation of pediatric asthma exacerbations and its association with asthma phenotypes.儿童哮喘急性加重的季节性变化及其与哮喘表型的关联。
Pediatr Res. 2025 May 7. doi: 10.1038/s41390-025-04073-2.
2
Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and red cell distribution width as prognostic indicators for length of hospital stay in pediatric asthma.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值以及红细胞分布宽度作为小儿哮喘住院时间的预后指标。
Saudi Med J. 2025 Feb;46(2):143-149. doi: 10.15537/smj.2025.46.2.20240934.
3
Asthma Risk Prevalence and Associated Factors in Stunted Children: A Study Using Asthma Predictive Index.发育迟缓儿童的哮喘风险患病率及相关因素:一项使用哮喘预测指数的研究
Medicina (Kaunas). 2025 Jan 16;61(1):140. doi: 10.3390/medicina61010140.
4
Association between vitamin D status at 3 years and eosinophilic asthma in 6-year-old children with a history of severe bronchiolitis.3岁时维生素D状态与有重度细支气管炎病史的6岁儿童嗜酸性粒细胞性哮喘之间的关联
Thorax. 2025 Feb 17;80(3):180-183. doi: 10.1136/thorax-2024-222099.
5
Mediated Mendelian randomization analysis to determine the role of immune cells in regulating the effects of plasma metabolites on childhood asthma.中介孟德尔随机化分析确定免疫细胞在调节血浆代谢物对儿童哮喘影响中的作用。
Medicine (Baltimore). 2024 Jul 26;103(30):e38957. doi: 10.1097/MD.0000000000038957.
6
Current Challenges in Pediatric Asthma.小儿哮喘的当前挑战
Children (Basel). 2024 May 24;11(6):632. doi: 10.3390/children11060632.
7
Targeting eosinophils: another strategy for asthma treatment.靶向嗜酸性粒细胞:哮喘治疗的另一种策略。
Clin Exp Pediatr. 2021 May;64(5):223-224. doi: 10.3345/cep.2021.00017. Epub 2021 Mar 5.

本文引用的文献

1
Efficacy of Intravenous Reslizumab in Oral Corticosteroid-Dependent Asthma.静脉注射瑞利珠单抗治疗口服皮质类固醇依赖型哮喘的疗效。
J Allergy Clin Immunol Pract. 2020 Feb;8(2):555-564. doi: 10.1016/j.jaip.2019.09.036. Epub 2019 Oct 15.
2
Severe asthma during childhood and adolescence: A longitudinal study.儿童和青少年时期严重哮喘:一项纵向研究。
J Allergy Clin Immunol. 2020 Jan;145(1):140-146.e9. doi: 10.1016/j.jaci.2019.09.030. Epub 2019 Oct 14.
3
Blood Eosinophilia May Not Adequately Estimate Lung Fluid Eosinophilia in Childhood Asthma.血嗜酸性粒细胞增多可能无法充分评估儿童哮喘中的肺组织嗜酸性粒细胞增多情况。
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2497-2498. doi: 10.1016/j.jaip.2019.05.008.
4
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype.孟鲁司特钠联合布地奈德治疗儿童哮喘的临床疗效观察
J Allergy Clin Immunol. 2019 Nov;144(5):1336-1342.e7. doi: 10.1016/j.jaci.2019.08.005. Epub 2019 Aug 16.
5
Remission of persistent childhood asthma: Early predictors of adult outcomes.儿童哮喘持续缓解:成人结局的早期预测指标。
J Allergy Clin Immunol. 2019 May;143(5):1752-1759.e6. doi: 10.1016/j.jaci.2018.09.038. Epub 2018 Nov 14.
6
Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma.瑞利珠单抗治疗嗜酸性粒细胞性哮喘患者的长期安全性和疗效。
J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1572-1581.e3. doi: 10.1016/j.jaip.2017.08.024.
7
Risk Factors Associated with Asthma Development and Control in Children. Mouse Infestation, Antipyretics, Respiratory Viruses, and Allergic Sensitization.与儿童哮喘发生和控制相关的风险因素。小鼠感染、退热药、呼吸道病毒和过敏致敏。
Am J Respir Crit Care Med. 2017 Dec 15;196(12):1605-1607. doi: 10.1164/rccm.201704-0696RR.
8
Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab.体重调整的静脉注射瑞利珠单抗治疗对固定剂量皮下美泊利珠单抗应答不足的重症哮喘。
Am J Respir Crit Care Med. 2018 Jan 1;197(1):38-46. doi: 10.1164/rccm.201707-1323OC.
9
Eosinophilic and Noneosinophilic Asthma.嗜酸性粒细胞性和非嗜酸性粒细胞性哮喘
Am J Respir Crit Care Med. 2018 Jan 1;197(1):22-37. doi: 10.1164/rccm.201611-2232PP.
10
Correlation of induced sputum eosinophil levels with clinical parameters in mild and moderate persistent asthma in children aged 7-18 years.7至18岁儿童轻度和中度持续性哮喘患者诱导痰嗜酸性粒细胞水平与临床参数的相关性
J Asthma. 2018 Apr;55(4):385-390. doi: 10.1080/02770903.2017.1338725. Epub 2017 Jul 11.